Newsletter | July 21, 2025

07.21.25 -- Winning With The Right Marbles: The Future Of Generics

FEATURED ARTICLE

Winning With The Right Marbles: The Future Of Generics

After decades of racing to the bottom on pricing, a revolution is coming to the U.S. generics market, writes Yaral Pharma CEO Stephen Beckman.

INDUSTRY INSIGHTS

Set Up And Qualify GMP Laboratories

Eurofins PSS established and qualified a GMP microbiology lab in Ireland, providing expertise, staffing, training, and project management to ensure compliant operations and client success.

Bio-Based Polymers Towards Net Zero In Single-Use Bioprocessing

Decarbonizing healthcare and pharmaceuticals is vital to meet climate goals and safeguard public health. Learn more about the need to act swiftly to reduce emissions and navigate global supply chains.

What Treatment Options Do You Have For Me?

It’s the most important question from a patient-centric perspective. Examine the complexities surrounding patient access to treatment options, particularly in the context of clinical trials.

9 Strategies To Increase Enrollment In Clinical Trials

An effective participant enrollment strategy is crucial to ensuring clinical trial success and avoiding missed deadlines, increased costs, and flawed trial outcomes.

CLD To Upstream Optimization: Enhancing Biologics Quality, Productivity

Explore how advanced cell line development and upstream processing strategies optimize both productivity and therapeutic effectiveness, ensuring the development of high-quality biologics.

Reduce Patient And Site Burden Through Excellence In Trial Logistics

Watch an insightful webinar where you’ll see the latest strategies and innovations for managing clinical trial operations with a focus on device provisioning and data workflows.

How Pharmaceutical Manufacturers Can Take Control Of Their Supply Chain

In an increasingly competitive and regulated landscape, the right ERP system is no longer optional. It’s essential to reclaim control and drive growth in pharmaceutical manufacturing.

N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit

A mid-to-large biopharma wanted to increase productivity in their fed-batch facility and reduce their current cost of goods (COGS). Learn what change in their process helped to meet their goals.